HERON THERAPEUTICS, INC. /DE/ — Director's Dealing 2017

Dec 20, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HERON THERAPEUTICS, INC. /DE/ (HRTX)
CIK: 0000818033
Period of Report: 2017-12-18

Reporting Person: TANG KEVIN C (Director, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-12-18	Stock Option (right to buy)	$17.00	A	17000	Acquired	2027-12-18	Common Stock (17000)	Direct

Footnotes

F1: The stock option vests and becomes exercisable in 12 equal monthly installments beginning one month after the date of grant.